SALIVARY GLAND CARCINOMA
Clinical trials for SALIVARY GLAND CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SALIVARY GLAND CARCINOMA trials appear
Sign up with your email to follow new studies for SALIVARY GLAND CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new drug combo shrink Hard-to-Treat salivary gland tumors?
Disease control OngoingThis phase 2 trial is testing whether an experimental drug called 9-ING-41, when combined with the chemotherapy drug carboplatin, can help people with advanced or metastatic salivary gland cancer. The study aims to see if the combination can shrink tumors or slow their growth. Pa…
Matched conditions: SALIVARY GLAND CARCINOMA
Phase: PHASE2 • Sponsor: Glenn J. Hanna • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New proton beam therapy aims to zap head and neck cancer with fewer side effects
Disease control OngoingThis study is testing whether a precise form of radiation called proton therapy can control head and neck cancer after surgery as well as standard X-ray radiation, but with fewer side effects. About 174 adults with newly diagnosed head and neck cancer will receive either proton t…
Matched conditions: SALIVARY GLAND CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New combo therapy targets rare salivary gland cancer
Disease control OngoingThis study tests a combination of hormone therapy (goserelin) and an immunotherapy drug (pembrolizumab) in 20 people with advanced salivary gland cancer that cannot be removed by surgery or radiation. The goal is to see if the treatment shrinks tumors or slows the disease. Partic…
Matched conditions: SALIVARY GLAND CARCINOMA
Phase: PHASE2 • Sponsor: Manish Patel • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug combo shows promise for rare salivary gland cancer
Disease control OngoingThis study tests whether a combination of two hormone-blocking drugs (apalutamide and a GnRH agonist) can shrink or slow the growth of advanced salivary gland cancer that has a specific protein called the androgen receptor. About 31 adults with locally advanced or spread cancer t…
Matched conditions: SALIVARY GLAND CARCINOMA
Phase: PHASE2 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Keytruda takes on 15 advanced cancers in major trial
Disease control OngoingThis phase 2 trial tests the immunotherapy drug pembrolizumab (Keytruda) in people with 15 types of advanced solid tumors that have worsened after standard treatments. About 1,600 participants receive the drug to see if their tumors shrink or stop growing. The study also looks fo…
Matched conditions: SALIVARY GLAND CARCINOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New PET tracer could spot cancers that standard scans overlook
Diagnosis OngoingThis phase 1 trial is testing a new imaging tracer called 68Ga-FAPI-46 to see where it collects in normal and cancerous tissues. About 30 people with various solid tumors or blood cancers will receive the tracer and then undergo a PET/CT scan. The goal is to understand how the tr…
Matched conditions: SALIVARY GLAND CARCINOMA
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC